vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Snail, Inc. (SNAL). Click either name above to swap in a different company.

Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $14.7M, roughly 1.7× IRIDEX CORP). On growth, Snail, Inc. posted the faster year-over-year revenue change (-4.2% vs -69.7%). Over the past eight quarters, Snail, Inc.'s revenue compounded faster (33.4% CAGR vs 11.9%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....

IRIX vs SNAL — Head-to-Head

Bigger by revenue
SNAL
SNAL
1.7× larger
SNAL
$25.1M
$14.7M
IRIX
Growing faster (revenue YoY)
SNAL
SNAL
+65.5% gap
SNAL
-4.2%
-69.7%
IRIX
Faster 2-yr revenue CAGR
SNAL
SNAL
Annualised
SNAL
33.4%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
SNAL
SNAL
Revenue
$14.7M
$25.1M
Net Profit
$-862.2K
Gross Margin
37.2%
38.3%
Operating Margin
-6.0%
Net Margin
-3.4%
Revenue YoY
-69.7%
-4.2%
Net Profit YoY
-177.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
SNAL
SNAL
Q4 25
$14.7M
$25.1M
Q3 25
$12.5M
$13.8M
Q2 25
$13.6M
$22.2M
Q1 25
$11.9M
$20.1M
Q4 24
$12.7M
$26.2M
Q3 24
$11.6M
$22.5M
Q2 24
$12.6M
$21.6M
Q1 24
$11.8M
$14.1M
Net Profit
IRIX
IRIX
SNAL
SNAL
Q4 25
$-862.2K
Q3 25
$-1.6M
$-7.9M
Q2 25
$-994.0K
$-16.6M
Q1 25
$-1.7M
$-1.9M
Q4 24
$-834.0K
$1.1M
Q3 24
$-1.9M
$235.1K
Q2 24
$-2.7M
$2.3M
Q1 24
$-3.5M
$-1.8M
Gross Margin
IRIX
IRIX
SNAL
SNAL
Q4 25
37.2%
38.3%
Q3 25
32.1%
0.1%
Q2 25
34.5%
31.3%
Q1 25
42.5%
29.1%
Q4 24
44.0%
43.3%
Q3 24
37.3%
38.6%
Q2 24
40.7%
37.5%
Q1 24
37.9%
14.7%
Operating Margin
IRIX
IRIX
SNAL
SNAL
Q4 25
-6.0%
Q3 25
-11.3%
-71.3%
Q2 25
-6.9%
-8.2%
Q1 25
-1.7%
-20.4%
Q4 24
-3.9%
11.5%
Q3 24
-16.1%
1.8%
Q2 24
-20.9%
12.4%
Q1 24
-28.0%
-15.6%
Net Margin
IRIX
IRIX
SNAL
SNAL
Q4 25
-3.4%
Q3 25
-12.6%
-56.9%
Q2 25
-7.3%
-74.7%
Q1 25
-14.2%
-9.7%
Q4 24
-6.6%
4.3%
Q3 24
-16.7%
1.0%
Q2 24
-21.2%
10.4%
Q1 24
-29.5%
-12.6%
EPS (diluted)
IRIX
IRIX
SNAL
SNAL
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
$-0.44
Q1 25
$-0.10
$-0.06
Q4 24
$-0.05
$0.03
Q3 24
$-0.12
$0.01
Q2 24
$-0.16
$0.06
Q1 24
$-0.21
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
SNAL
SNAL
Cash + ST InvestmentsLiquidity on hand
$6.0M
$8.6M
Total DebtLower is stronger
$14.6M
Stockholders' EquityBook value
$-16.4M
Total Assets
$29.2M
$59.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
SNAL
SNAL
Q4 25
$6.0M
$8.6M
Q3 25
$5.6M
$12.3M
Q2 25
$6.8M
$7.9M
Q1 25
$7.2M
$9.4M
Q4 24
$2.4M
$7.3M
Q3 24
$3.9M
$10.6M
Q2 24
$4.1M
$15.5M
Q1 24
$5.4M
$16.1M
Total Debt
IRIX
IRIX
SNAL
SNAL
Q4 25
$14.6M
Q3 25
$10.5M
Q2 25
$11.8M
Q1 25
$9.0M
Q4 24
$1.0M
$5.7M
Q3 24
$1.4M
$5.7M
Q2 24
$5.8M
Q1 24
$6.5M
Stockholders' Equity
IRIX
IRIX
SNAL
SNAL
Q4 25
$-16.4M
Q3 25
$4.7M
$-15.6M
Q2 25
$6.1M
$-8.0M
Q1 25
$852.0K
$9.1M
Q4 24
$2.1M
$9.7M
Q3 24
$2.6M
$8.2M
Q2 24
$4.2M
$7.9M
Q1 24
$6.5M
$5.6M
Total Assets
IRIX
IRIX
SNAL
SNAL
Q4 25
$29.2M
$59.3M
Q3 25
$28.4M
$51.1M
Q2 25
$31.6M
$58.0M
Q1 25
$34.2M
$64.5M
Q4 24
$29.1M
$62.2M
Q3 24
$30.2M
$66.8M
Q2 24
$31.2M
$75.4M
Q1 24
$34.1M
$78.3M
Debt / Equity
IRIX
IRIX
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
0.99×
Q4 24
0.48×
0.59×
Q3 24
0.53×
0.70×
Q2 24
0.73×
Q1 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
SNAL
SNAL
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
SNAL
SNAL
Q4 25
$-5.3M
Q3 25
$-1.2M
$6.6M
Q2 25
$-397.0K
$-3.2M
Q1 25
$-1.1M
$764.5K
Q4 24
$-1.2M
$-3.6M
Q3 24
$-3.1M
$-5.0M
Q2 24
$-1.3M
$206.6K
Q1 24
$-1.6M
$6.8M
Free Cash Flow
IRIX
IRIX
SNAL
SNAL
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
IRIX
IRIX
SNAL
SNAL
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
IRIX
IRIX
SNAL
SNAL
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
IRIX
IRIX
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.21×
Q3 24
-21.05×
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRIX
IRIX

Segment breakdown not available.

SNAL
SNAL

Pc$14.7M59%
Platform Three$5.2M21%
Platform Two$3.3M13%
Sales Channel Directly To Consumer Mobile Sale$1.6M6%

Related Comparisons